The extract’s low IC50 value against the non-small-cell lung cancer cell line H1299, which is p53-deficient and resistant to multifractionated radiotherapy [45], prompts further investigation into the specific cellular pathways involved and the precise type of cell death that the extract induces. The gene discussed is TP53; the disease is non-small cell lung carcinoma.